Cost-effectiveness analysis of mass screening for cervical cancer in Japan

Journal of Epidemiology

Volumn 7, Issue 3, 1997, Pages 135-141

  Matsunaga, Gen ^a,b   Tsuji, Ichiro ^b   Sato, Shinji ^a   Fukao, Akira ^c   Hisamichi, Shigeru ^b   Yajima, Akira ^a  

^a Department of Obstetrics and Gynecology ^*  (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Cost effectiveness analysis; Mass screening; Simulation study

Indexed keywords

ADULT; ARTICLE; CARCINOMA IN SITU; COHORT ANALYSIS; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HUMAN; JAPAN; MASS SCREENING; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADULT; CARCINOMA IN SITU; COHORT STUDIES; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; JAPAN; MASS SCREENING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0344175077     PISSN: 09175040     EISSN: None     Source Type: Journal    
DOI: 10.2188/jea.7.135     Document Type: Article

References (17)

1. Kuroishi T. Evaluation of the efficacy of mass screening for uterine cancer in Japan. Jpn J Cancer Res (Gann) 1986; 77: 399-405.
2. Gao CM, Kuroishi T, Tajima K. An epidemiological evaluation of the efficacy of mass screening for uterine cancer: The relationship between coverage rate of mass screening and reduction in mortality and morbidity of uterine cancer. Jpn J Cancer Clin 1993; 39 (4): 373-380 (in Japanese).
3. Sobue T, Suzuki T, Hashimoto S, et al. A case-control study of the effectiveness of cervical cancer screening in Osaka, Japan. Jpn J Cancer Res (Gann) 1988; 79: 1269.
4. Makino H, Sato S, Yajima A, et al. Case-control study of the effectiveness of mass screening in reducing invasive cervical cancer. Acta Obst Gynaec Jpn 1991; 43 (9): 1226-1232 (in Japanese).
5. Noda K, Teshima K. Effectiveness and future direction of cervical cancer screening: cost-benefit of cervical cancer screening. Jpn J Cancer Clin 1983; 29 (6): 483-487 (in Japanese).
6. Iinuma T. Cancer screening and cost-effectiveness. Innervision 1989; 4: 73-75 (in Japanese).
7. Tsukuma H, Kitagawa T, Hanoi A, et al. Incidence of cancer predictions in Japan up to the year 2015. Jpn J Cancer Clin 1992; 38 (1): 1-10 (in Japanese).
8. Eisenberg JM. Clinical economics: A guide to the economic analysis of clinical practice. J.A.M.A. 1989; 262: 2879-2886.
9. Tsuji I, Fukao A, Hisamichi S,et al. Cost-effectiveness analysis of screening for gastric cancer in Japan. Tohoku J Exp Med 1991; 164: 279-284.
10. Tsuji I, Fukao A, Hisamichi S, et al. Cost-effectiveness analysis of screening for colorectal cancer in Japan. Tohoku J Exp Med 1991; 164: 269-278.
11. Yamanobe T. The 29th Annual Report of Gynecology Tumor Committee. Acta Obst Gynaec Jpn 1993; 45: 161-198 (in Japanese).
12. Ishida T, Tanaka A, Uehata M. Accuracy of mass screening for uterine cancer. 1993 Annual Report of the Research on the Development of Effective Methods for Mass Screening Program. Japan Association of Public Health, Tokyo, Japan, 1994.
13. Ministry of Health and Welfare. The 17th Life Tables. Tokyo, Japan 1992 (in Japanese).
14. Japan Cancer Association. Annual Report of Cancer Association. Tokyo, Japan 1989 (in Japanese).
15. Dummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programs. Oxford University Press 1989.
16. U.S.Congress, Office of Technology Assessment. Cost and Effectiveness of Cervical Cancer Screening in Elderly Women. U.S.G.P.O., Washington D. C. 1990.
17. Eddy DM. Screening for Cervical Cancer. Annals of Internal Medicine 1990; 113: 214-226.